GLP-1-Mediated Targeting of Inflammation Corrects Obesogenic Memory in Male Mice
- PMID: 40215332
- DOI: 10.2337/db24-1071
GLP-1-Mediated Targeting of Inflammation Corrects Obesogenic Memory in Male Mice
Abstract
Weight loss defense mechanisms and inflammation challenge metabolic disease management, with few treatments available. We developed a mouse model of obesogenic memory and investigated the efficacy of a glucagon-like peptide 1/dexamethasone (GLP-1/Dexa) conjugate that safely and cell-selectively targets inflammation in GLP-1 receptor cells. GLP-1/Dexa offers a promising strategy to correct obesogenic memory and adipose tissue inflammation in male mice. CCR2 monocytes contribute to glucose intolerance associated with obesogenic memory and may be targeted by GLP-1/Dexa.
© 2025 by the American Diabetes Association.
Comment in
-
Targeting Adipose Inflammation and Energy Expenditure to Sustain Metabolic Health After Weight Loss.Diabetes. 2025 Sep 1;74(9):1464-1465. doi: 10.2337/dbi25-0027. Diabetes. 2025. PMID: 40834243 No abstract available.
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources